SCHEMBL22928679

SCHEMBL22928679

CN(F)c1cccnc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL518808 0.81
SCHEMBL29435745 0.81
SCHEMBL1507818 0.81
SCHEMBL3409401 0.81 KCNA5 (0.49)
SCHEMBL3409704 0.80 CYP2A6 (0.50)
Hydrochloric Acid SCHEMBL4024971 0.79 KCNA5 (0.47)
Hydrochloric Acid SCHEMBL5755597 0.79 CHRM5 (0.48)
Hydrochloric Acid SCHEMBL28182705 0.79 CHRM5 (0.48)
SCHEMBL4077802 0.77
SCHEMBL1629081 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3380101-B1 EIF4-A-INHIBITING COMPOUNDS AND METHODS RELATED THERETO EFFECTOR THERAPEUTICS INC (US) 2021-01-27 EP disclosed
CN-104703623-B For the Compounds and methods for and indication of kinases regulation 普莱希科公司 2017-06-23 CN disclosed